Search

Search Constraints

You searched for: Author/Creator Adra, Nabil

Search Results

1. 340 Phase 1 study of AMG 160, a half-life extended BiTE® (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer. (10th December 2020)

2. A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer. (1st November 2020)

3. Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management. Issue 2 (8th October 2019)

5. Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. (2021)

6. Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer. Issue 3 (16th November 2022)

8. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours. Issue 10 (3rd October 2021)